Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Drug Safety|December 4, 2025
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert ConsensusAnna Fettiplace, Arie Regev, Alexandre Kiazand, et al.
Plos Medicine|May 1, 2019
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trialZita-Rose Manjaly Thomas, Iman Satti, Julia L Marshall, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccinesStephanie A Harris, Andrew White, Lisa Stockdale, et al.
Scientific Reports|May 13, 2022
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical studyMorven Wilkie, Rachel Tanner, Daniel Wright, et al.
Vaccine|November 19, 2019
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adultsMorven Wilkie, Iman Satti, Alice Minhinnick, et al.
Cancer|January 29, 2025
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancerJacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, et al.
The New England Journal of Medicine|June 2, 2025
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based ChemotherapyGiannis Mountzios, Longhua Sun, Byoung Chul Cho, et al.
American Journal of Hematology|February 6, 2024
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemiaElias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, et al.
Pageof 6